The DOI matches its Crossref record.
In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Strains harboring a D239L, S225R, N146K substitution or a 259–260 insertion in PBP2A had ceftobiprole MICs of 4–8 mg/L [73,74].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 14
- Liapikou, 2015, Ceftobiprole for the treatment of pneumonia: a European perspective, Drug Des Devel Ther, 9, 4565
- Lowy, 1998, Staphylococcus aureus infections, N Engl J Med, 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
- Leprince, 2015, Distribution and antimicrobial susceptibility of bacteria from adults with community-acquired pneumonia or complicated skin and soft tissue infections in France: the nationwide French PREMIUM study, Diagn Microbiol Infect Dis, 83, 175, 10.1016/j.diagmicrobio.2015.06.007 · doi:10.1016/j.diagmicrobio.2015.06.007
- Miliani, 2015, National point prevalence survey of healthcare-associated infections and antimicrobial use in French home care settings. May to June 2012, Euro Surveill Bull, 20
- Montravers, 2016, Current and future considerations for the treatment of hospital-acquired pneumonia, Adv Ther, 10.1007/s12325-016-0293-x · DOI
- Rouzic, 2010, Prompt and successful toxin-targeting treatment of three patients with necrotizing pneumonia due to Staphylococcus aureus strains carrying the Panton-Valentine leukocidin genes, J Clin Microbiol, 48, 1952, 10.1128/JCM.01892-09 · DOI
- Saravolatz, 2010, In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA), Int J Antimicrob Agents, 36, 478, 10.1016/j.ijantimicag.2010.07.016 · doi:10.1016/j.ijantimicag.2010.07.016
- Rossolini, 2011, Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study, J Antimicrob Chemother, 66, 151, 10.1093/jac/dkq397 · doi:10.1093/jac/dkq397
- Farrell, 2014, Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010, Antimicrob Agents Chemother, 58, 3882, 10.1128/AAC.02465-14 · doi:10.1128/aac.02465-14
- Jean, 2015, Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART), J Microbiol Immunol Infect
- Banerjee, 2008, In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus, Antimicrob Agents Chemother, 52, 2089, 10.1128/AAC.01403-07 · DOI
- Alm, 2014, Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective, J Antimicrob Chemother, 69, 2065, 10.1093/jac/dku114 · DOI
- Dauwalder, 2008, Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007, J Clin Microbiol, 46, 3454, 10.1128/JCM.01050-08 · DOI
- Pillar, 2008, In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin, J Antimicrob Chemother, 61, 595, 10.1093/jac/dkm492 · DOI
Cited by
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Metadata
- Authors
- Hodille, E., Delouere, L., Bouveyron, C., Meugnier, H., Bes, M., Tristan, A., Laurent, F., Vandenesch, F., Lina, G., & Dumitrescu, O.
- Venue
- Médecine et Maladies Infectieuses
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 47
- Issue
- 2
- Pages
- 152-157
- ISSN
- 0399-077X
- Cited by
- 16
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections. https://app.cochat.ai/papers/10.1016/j.medmal.2016.10.004
- The paper
- Hodille, E., Delouere, L., Bouveyron, C., Meugnier, H., Bes, M., Tristan, A., Laurent, F., Vandenesch, F., Lina, G., & Dumitrescu, O. (2017). In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections. Médecine et Maladies Infectieuses. https://doi.org/10.1016/j.medmal.2016.10.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.